Advanced search
Publication Cover
Acta Oncologica Volume 50, 2011 - Issue 3
Journal homepage
1,088
Views
1
CrossRef citations to date
0
Altmetric
Letter

Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma

Fotios V. Michelis Department of Hematology and Lymphoma, Evangelismos Hospital, Athens, GreeceCorrespondence[email protected]
,
Demitrios N. Exarhos Department of Computed Tomography and Magnetic Resonance Imaging, Evangelismos Hospital, Athens, Greece
,
Ifigenia A. Tzannou Department of Hematology and Lymphoma, Evangelismos Hospital, Athens, Greece
,
Themistoklis Karmiris Department of Hematology and Lymphoma, Evangelismos Hospital, Athens, Greece
&
Emmanouil Nikiforakis Department of Hematology and Lymphoma, Evangelismos Hospital, Athens, Greece
Pages 474-476 | Received 26 May 2010, Accepted 14 Jul 2010, Published online: 17 Aug 2010

References

  • Newman JS, Francis JR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: Correlation with CT. Radiology 1994;190:111–6.
  • Thill R, Neuerburg J, Fabry U, Cremerius U, Wagenknecht G, Hellwig D, . Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma. Nuklearmedizin 1997;36:234–9.
  • Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: Effectiveness and comparison with computed tomography. Eur J Nuclear Med 1998;25:721–8.
  • Schaefer NG, Hany TF, Taverna C, Seifert B, Stumpe KD, von Schulthess GK, . Non-Hodgkin lymphoma and Hodgkin disease: Coregistered FDG PET and CT at staging and restaging: Do we need contrast-enhanced CT? Radiology 2004;232:823–9.
  • Jerusalem G, Warland V, Najjar F, Paulus P, Fassotte MF, Fillet G, . Wholebody 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nucl Med Commun 1999;20:13–20.
  • Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, . Extranodal malignant lymphoma: Detection with FDG PET versus CT. Radiology 1998;206: 475–81.
  • Raanani P, Shasha Y, Perry C, Metser U, Naparstek E, Apter S, . Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol 2006;17:117–22.
  • Franklin J, Diehl V. Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP. Ann Oncol 2002;13(Suppl 1):98–101.
  • Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, . Wholebody 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol 1998; 9:1117–22.
  • Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, . Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 2001;86:266–73.
  • Rodríguez-Vigil B, Gómez-León N, Pinilla I, Hernández-Maraver D, Coya J, Martín-Curto L, . PET/CT in lymphoma: Prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. J Nucl Med 2006; 47:1643–8.
  • Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, . Use of positron emission tomography for response assessment of lymphoma: Consensus recommendations of the Imaging Subcommittee of the International Harmonization Project in Lymphoma. J Clin Oncol 2007;25:571–8.
  • Pakos EE, Fotopoulos AD, Ioannidis JP. 18FFDG PET for evaluation of bone marrow infiltration in staging of lymphoma: A meta-analysis. J Nucl Med 2005;46:958–63.
  • Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, Hänel A, Bredow J, . Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Br J Cancer 2004;90:620–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.